Source map — AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Investing.com | news | 60% |
| Yahoo Finance | news | 60% |
| Endpoints News | news | 60% |
| Axios | news | 60% |
| Fierce Biotech | news | 60% |
| AbbVie News Center | news | 60% |
| WSJ | news | 60% |
| CNBC | news | 60% |
| qz.com | news | 60% |
| FirstWord Pharma | news | 60% |
| statnews.com | news | 60% |
| Barron's | news | 60% |
| BioPharma Dive | news | 60% |
| Seeking Alpha | news | 60% |
| TradingView | news | 60% |
| NBC Boston | news | 60% |
| Morningstar | news | 60% |
| The Business Journals | news | 60% |
| Investor's Business Daily | news | 60% |
| news.abbvie.com | news | 50% |
| www.prnewswire.com | news | 50% |
| marketchameleon.com | news | 50% |
| aijourn.com | news | 50% |
| www.stocktitan.net | news | 50% |
| prconnect.thestreet.com | news | 50% |